NCT00432861
Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis treatment 3 completed NCT01879228
Effect of Chronic Incretin-based Therapy in Cystic Fibrosis other Not Available completed NCT00705978
Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis treatment 3 completed NCT00095732
Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency treatment 2 completed NCT00880100
Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF) treatment 3 completed NCT00572975
Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea No drug interventions diagnostic 4 completed NCT00406536
Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI No drug interventions supportive_care 2 completed NCT00513682
Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI) treatment 3 completed NCT01851694
Beta-cell Response to Incretin Hormones in Cystic Fibrosis No drug interventions other Not Available recruiting NCT00763412
Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis other Not Available completed NCT01012908
Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency No drug interventions treatment 2 / 3 unknown_status NCT03279653
Pancreatic Exocrine Insufficiency After Bariatric Surgery No drug interventions Not Available Not Available unknown_status NCT01144507
Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis No drug interventions Not Available Not Available completed NCT00535756
Creon After Pancreatic Surgery treatment 4 completed NCT03551691
Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI) treatment 2 completed NCT01710644
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis treatment 1 / 2 completed NCT02979340
MRI to Characterize and Predict CF Liver Disease in PUSH Cohort No drug interventions Not Available Not Available completed NCT02985801
PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer treatment 1 / 2 terminated NCT05700604
Hypoglycemia and Glucagon Response in CF No drug interventions Not Available Not Available completed NCT04731272
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance other 2 recruiting NCT03450772
Equivalence Study to Compare Two Strengths of Creon in China treatment 3 unknown_status NCT01988350
Pancreatic Insufficiency Secondary to Tobacco Exposure No drug interventions Not Available Not Available completed NCT05466838
PERT to Improve Quality of Life in Patients Undergoing Pancreaticoduodenectomy: A Pilot Randomized Controlled Trial No drug interventions treatment Not Available recruiting